DK1496884T3 - Blanding af et antithrombotisk middel med aspirin og anvendelse heraf til behandling af atherothrombotiske sygdomme - Google Patents

Blanding af et antithrombotisk middel med aspirin og anvendelse heraf til behandling af atherothrombotiske sygdomme

Info

Publication number
DK1496884T3
DK1496884T3 DK03745819T DK03745819T DK1496884T3 DK 1496884 T3 DK1496884 T3 DK 1496884T3 DK 03745819 T DK03745819 T DK 03745819T DK 03745819 T DK03745819 T DK 03745819T DK 1496884 T3 DK1496884 T3 DK 1496884T3
Authority
DK
Denmark
Prior art keywords
aspirin
mixture
treatment
antithrombotic agent
atherothrombotic diseases
Prior art date
Application number
DK03745819T
Other languages
English (en)
Inventor
Gilbert Lavielle
Bernard Cimetiere
Tony Verbeuren
Marie-Odile Vallez
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1496884T3 publication Critical patent/DK1496884T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK03745819T 2002-04-05 2003-04-04 Blanding af et antithrombotisk middel med aspirin og anvendelse heraf til behandling af atherothrombotiske sygdomme DK1496884T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine

Publications (1)

Publication Number Publication Date
DK1496884T3 true DK1496884T3 (da) 2006-10-02

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03745819T DK1496884T3 (da) 2002-04-05 2003-04-04 Blanding af et antithrombotisk middel med aspirin og anvendelse heraf til behandling af atherothrombotiske sygdomme

Country Status (27)

Country Link
US (1) US7618955B2 (da)
EP (1) EP1496884B1 (da)
JP (1) JP4065853B2 (da)
KR (1) KR100645143B1 (da)
CN (1) CN1297265C (da)
AR (1) AR039253A1 (da)
AT (1) ATE329591T1 (da)
AU (1) AU2003246774B2 (da)
BR (1) BR0309019A (da)
CA (1) CA2480697A1 (da)
CY (1) CY1105106T1 (da)
DE (1) DE60306133T2 (da)
DK (1) DK1496884T3 (da)
EA (1) EA006978B1 (da)
ES (1) ES2264533T3 (da)
FR (1) FR2838057B1 (da)
GE (1) GEP20074101B (da)
HK (1) HK1076034A1 (da)
MA (1) MA27114A1 (da)
MX (1) MXPA04009760A (da)
NO (1) NO20044700L (da)
NZ (1) NZ535430A (da)
PL (1) PL371620A1 (da)
PT (1) PT1496884E (da)
UA (1) UA79457C2 (da)
WO (1) WO2003084525A1 (da)
ZA (1) ZA200407593B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008001063A (es) * 2005-07-22 2008-03-19 Procter & Gamble Composiciones para reducir la incidencia de arritmia inducida por farmacos.
AU2008239659B2 (en) 2007-04-13 2013-09-05 Millennium Pharmaceuticals, Inc. Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
NO20044700L (no) 2004-10-29
NZ535430A (en) 2006-09-29
CY1105106T1 (el) 2009-11-04
WO2003084525A1 (fr) 2003-10-16
ZA200407593B (en) 2006-07-26
KR20040098053A (ko) 2004-11-18
UA79457C2 (en) 2007-06-25
EP1496884B1 (fr) 2006-06-14
US7618955B2 (en) 2009-11-17
FR2838057B1 (fr) 2005-07-08
BR0309019A (pt) 2005-02-01
DE60306133D1 (de) 2006-07-27
ATE329591T1 (de) 2006-07-15
KR100645143B1 (ko) 2006-11-10
EA200401293A1 (ru) 2005-02-24
AR039253A1 (es) 2005-02-16
ES2264533T3 (es) 2007-01-01
DE60306133T2 (de) 2007-01-04
CN1646111A (zh) 2005-07-27
MXPA04009760A (es) 2004-12-13
US20050143354A1 (en) 2005-06-30
GEP20074101B (en) 2007-05-10
AU2003246774B2 (en) 2007-02-15
FR2838057A1 (fr) 2003-10-10
MA27114A1 (fr) 2004-12-20
EA006978B1 (ru) 2006-06-30
PL371620A1 (en) 2005-06-27
JP2005528376A (ja) 2005-09-22
JP4065853B2 (ja) 2008-03-26
EP1496884A1 (fr) 2005-01-19
CN1297265C (zh) 2007-01-31
AU2003246774A1 (en) 2003-10-20
HK1076034A1 (en) 2006-01-06
CA2480697A1 (fr) 2003-10-16
PT1496884E (pt) 2006-09-29

Similar Documents

Publication Publication Date Title
IS7348A (is) N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma
IS7699A (is) Afleiður af díoxan-2-alkýl karbamötum, framleiðslu aðferð þeirra og notkun við meðferð sjúkdóma
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DK1663978T3 (da) Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
DK1765322T3 (da) Retinal-derivater og fremgangsmåder til anvendelse deraf i behandlingen af synsforstyrrelser
DK0966436T3 (da) Arylsulfonamider og analoger deraf og anvendelse deraf til behandling af neurodegenerative lidelser
DK1487541T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelse af perifere vaskulære sygdomme
DK1626728T3 (da) Oxiderede lipider og anvendelse heraf ved behandling af inflammatoriske sygdomme og forstyrrelser
DK1003479T3 (da) Fremgangsmåde og sammensætninger til behandling af allergiske senfasereaktioner og inflammatoriske sygdomme
IS8123A (is) Ný heteróhringlaga efnasambönd sem eru gagnleg í meðhöndlun á bólgu- og ofnæmissjúkdómum; aðferðir til að framleiða þau og lyfjablöndur sem innihaldaþau
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
IS8134A (is) Píperasínafleiður og notkun þeirra til að meðhöndla tauga- og geðsjúkdóma
IS8410A (is) Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
IS8497A (is) Aðferðir og hvarfefni til að meðhöndla bólgusjúkdóma
DK1848415T3 (da) Kombinationsterapi med glatirameracetat og rasagilin til behandling af multipel sklerose
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
DK1919290T3 (da) Fremgangsmåder og produkter til behandling af sygdomme
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DK1487418T3 (da) Lille CO-perle af DHA og rosmarin samt fremgangsmåder til anvendelse
IS6033A (is) Tálmar við amínótransferasa, sem háðir eru amínósýru með greinóttum keðjum, og notkun þeirra til meðhöndlunar á sjónusjúkdómum af völdum sykursýki
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
DK1667693T3 (da) Præparater og fremgangsmåder til anvendelse af lamellare bodies til terapeutiske formål
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
DK1496884T3 (da) Blanding af et antithrombotisk middel med aspirin og anvendelse heraf til behandling af atherothrombotiske sygdomme
DK1530462T3 (da) 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens